Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.30 |
| ▸ | RELA | Q04206 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20256197 | 0.84 | KDM4E (0.40) | DUSP3KDM4EMAPK1ATMNPC1 | |
| SCHEMBL19045226 | 0.83 | KDM4E (0.36) | DUSP3KDM4EMAPK1ATMALDH1A1 | |
| SCHEMBL19045218 | 0.82 | KDM4E (0.35) | DUSP3KDM4EMAPK1ATM | |
| SCHEMBL19045597 | 0.82 | KDM4E (0.35) | DUSP3KDM4EMAPK1ATMLMNA | |
| SCHEMBL19044523 | 0.82 | KDM4E (0.35) | DUSP3KDM4EMAPK1ATMLMNA | |
| SCHEMBL19044691 | 0.81 | KDM4E (0.33) | DUSP3KDM4EMAPK1ATM | |
| SCHEMBL19044857 | 0.80 | DUSP3 (0.30) | DUSP3 | |
| SCHEMBL19044402 | 0.80 | KDM4E (0.32) | DUSP3KDM4EMAPK1ATM | |
| SCHEMBL19044697 | 0.80 | MAPK1 (0.33) | KDM4EMAPK1ATMLMNA | |
| SCHEMBL19045612 | 0.79 | KDM4E (0.31) | DUSP3KDM4EMAPK1ATMNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11581497-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2023-02-14 | — | — | US | disclosed |
| US-20210320264-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11581497-B2 | Materials for organic electroluminescent devices | OR10J3, EPCAM, L1CAM | DUSP3 3411/4885KDM4E 2132/4885MAPK1 2838/4885 |
| US-20210320264-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | OR10J3, EPCAM, L1CAM | DUSP3 3411/4885KDM4E 2132/4885MAPK1 2838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.